24 years of historical data (2002–2025) · Healthcare · Biotechnology
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Pluri Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $27M | $31M | $30M | $29M | $40M | $111M | $161M | $77M | $129M | $112M | $106M |
| Enterprise Value | $55M | $60M | $53M | $54M | $59M | $105M | $154M | $72M | $120M | $107M | $100M |
| P/E Ratio → | -0.94 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 20.41 | 23.48 | 92.91 | 102.50 | 169.21 | — | 6995.13 | 1418.07 | 2582.50 | — | 37.16 |
| P/B Ratio | — | — | 5.59 | 1.92 | 1.23 | 1.95 | 2.87 | 3.51 | 4.53 | 3.70 | 2.77 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 44.55 | 162.93 | 188.02 | 250.54 | — | 6680.35 | 1342.03 | 2406.08 | — | 34.98 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Pluri Inc. earns an operating margin of -1659.9%. Operating margins have expanded from -9493.4% to -1659.9% over the past 3 years, signaling improving operational efficiency. A negative ROE of -992.7% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 49.0% | 49.0% | 98.8% | 96.9% | -350.0% | — | -6726.1% | 96.3% | 96.0% | — | 96.5% |
| Operating Margin | -1659.9% | -1659.9% | -6796.9% | -9493.4% | -17774.8% | — | -128156.5% | -65800.0% | -67462.0% | — | -819.1% |
| Net Profit Margin | -1690.3% | -1690.3% | -6407.4% | -9867.9% | -17624.8% | — | -126747.8% | -65383.3% | -52252.0% | — | -816.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -992.7% | -992.7% | -201.7% | -119.3% | -92.3% | -88.1% | -74.8% | -140.3% | -88.9% | -81.3% | -48.3% |
| ROA | -57.7% | -57.7% | -46.3% | -47.7% | -51.0% | -62.7% | -60.2% | -100.5% | -68.3% | -66.6% | -40.7% |
| ROIC | -59.9% | -59.9% | -48.8% | -44.9% | -61.3% | -76.4% | -66.4% | -142.5% | -111.9% | -73.1% | -51.9% |
| ROCE | -107.1% | -107.1% | -55.2% | -51.2% | -58.1% | -72.5% | -73.1% | -132.7% | -107.9% | -77.5% | -45.7% |
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $28M ($34M total debt minus $6M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 5.47 | 1.95 | 0.89 | 0.43 | 0.03 | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | — | 4.22 | 1.60 | 0.59 | -0.12 | -0.13 | -0.19 | -0.31 | -0.16 | -0.16 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -25.64 | -25.64 | -23.65 | -33.27 | -45.64 | -638.29 | -147.73 | -1217.48 | -27.88 | — | -233.19 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.68x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 7.37x to 0.68x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.68 | 0.68 | 6.98 | 7.37 | 8.46 | 5.85 | 6.07 | 3.23 | 3.75 | 5.36 | 6.16 |
| Quick Ratio | 0.68 | 0.68 | 6.98 | 7.37 | 8.46 | 5.85 | 6.07 | 3.15 | 3.75 | 5.36 | 6.16 |
| Cash Ratio | 0.64 | 0.64 | 6.73 | 7.15 | 8.06 | 5.64 | 5.80 | 2.91 | 3.50 | 4.82 | 5.58 |
| Asset Turnover | — | 0.03 | 0.01 | 0.01 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.06 |
| Inventory Turnover | — | — | — | — | — | — | — | 0.00 | — | — | — |
| Days Sales Outstanding | — | 197.25 | 714.33 | 670.23 | 2060.53 | — | 25550.00 | 9604.91 | 6183.10 | — | 318.08 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Pluri Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $6M | $5M | $5M | $4M | $4M | $2M | $2M | $1M | $1M | $994349 |
Compare PLUR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $27M | -0.9 | — | — | 49.0% | -1659.9% | -992.7% | -59.9% | — | |
| $280M | -2.1 | — | — | — | -2222.4% | -51.8% | -36.5% | — | |
| $2B | -3.6 | — | — | 76.5% | -651.7% | -53.5% | -44.0% | — | |
| $3B | -38.9 | — | — | 84.0% | -274.6% | -8.1% | -31.1% | — | |
| $297M | -1.7 | — | — | — | — | -198.1% | — | — | |
| $5B | -8.1 | — | — | -6537.0% | -16191.4% | -30.2% | -22.3% | — | |
| $1B | -3.3 | — | — | 97.2% | -153.1% | -55.5% | -48.9% | — | |
| $6B | -46.2 | — | — | — | — | -87.5% | -50.3% | — | |
| $398M | -1.8 | — | — | — | — | -60.3% | -63.2% | — | |
| $22M | -0.2 | — | — | 100.0% | -179.9% | -185.4% | -178.8% | — | |
| $176B | 26.8 | 19.0 | 28.0 | 37.7% | 18.2% | 13.1% | 7.5% | 3.8 | |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 24 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Fate Therapeutics, Inc..
Start ComparisonQuick answers to the most common questions about buying PLUR stock.
Pluri Inc.'s current P/E ratio is -0.9x. This places it at the 50th percentile of its historical range.
Pluri Inc.'s return on equity (ROE) is -992.7%. The historical average is -157.8%.
Based on historical data, Pluri Inc. is trading at a P/E of -0.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Pluri Inc. has 49.0% gross margin and -1659.9% operating margin.